Keep HCQ Blood Levels Up to Avoid Cardiovascular Disease in Lupus
People taking hydroxychloroquine (HCQ) for systemic lupus erythematosus (SLE) showed markedly increased risk for atherosclerotic cardiovascular disease when blood levels of the drug were low and when long-term adherence was poor, a prospective study showed.
Read Article


